With some tweaks, CAR-T cancer therapy could be made safer — and more widely available — study suggests

A novel approach to CAR-T cancer therapy promises to upend what has become a truism in medicine: that the treatment’s dramatic effect on tumors comes with serious risks to patient safety.

In a small clinical trial, patients treated with a slightly modified version of an approved CAR-T saw benefits on par with previous studies but with none of the hallmark side effects that can leave some patients hospitalized and in need of costly extra treatments.